Spectrophotometric-dual-enzyme-simultaneous-assay (SDESA) for enzyme-linked-immunosorbent-assay (ELISA) of two components in one well is a patented platform when a special pair of labels is accessible. With microplate readers, alkaline phosphatase on 4-nitro-1-naphthylphosphate (4NNPP) served as label A; Pseudomonas aeruginosa arylsulfatase (PAAS) and acetylcholinesterase (AChE) on their substrates derived from 4-nitrophenol/analogue served as candidate label B, and were compared for SDESA with an engineered alkaline phosphatase of Eschrichia coli (ECAP). For SDESA, the interference from overlapped absorbance was corrected based on linear additivity of absorbance to derive initial rates reflected by absorbance change at 450 nm for ECAP and at 405 nm for PAAS or AChE, after the correction of spontaneous hydrolysis. For SDESA with ECAP, AChE already had sufficient activity in an optimized buffer; PAAS was more favorable for substrate stability and product absorbance except for lower activity. Therefore, PAAS engineered for sufficient activity plus alkaline phosphatase is absorbing for ELISA via SDESA.
Introduction
Enzyme-linked-immunosorbent-assay (ELISA) is a pivotal analytical technique widely used in biomedicine. The operation process of classical ELISA involves immuno-reaction, separation of immuno-complexes via adsorption of one component on surfaces of microplate wells, actions of enzyme labels on chromogenic substrates and assay of product absorbance with microplate readers. However, slow rates of immuno-reactions with immobilized components and the assay of one component in one well each time make ELISA a method of low efficiency. To accelerate ELISA, it is favorable for simultaneous ELISA of two components from one sample in one well via all of the same operations for classical ELISA. [1] [2] [3] More importantly, when the ratio of concentrations of two components in one sample is needed, separate assays always give results bearing unfavorably low precision. 4, 5 In this case, simultaneous assays of two components from one sample in one well are more preferable since there is better precision due to the covariance between concentrations of two components determined concomitantly with the sample.
Clearly, simultaneous ELISA of two components from one sample in one well requires simultaneous assays of activities of two enzyme labels in one well via concomitant initiation of reactions of two enzyme labels with two substrates and concurrent assays of absorbance of two chromogenic products. However, this technique is rather challenging, [6] [7] [8] [9] and has not been fully realized yet. Recently, spectrophotometric-dual-enzyme-simultaneousassay (SDESA) was developed in our laboratory and patented. [10] [11] [12] For SDESA, two wavelengths are swiftly altered to measure absorbance of two substrates/products of two enzymes at two timepoints or continuously at reasonable intervals. To eliminate interference from overlapped absorbance of substances involved in SDESA, a chemometric method based on linear additivity of absorbance of non-interacting substances is proposed to process data. ELISA via SDESA, denoted as SDESA-ELISA, has already been proven effective with conventional microplate readers equipped with standard filters centering on 405 and 450 nm. [10] [11] [12] [13] For routine practice, SDESA-ELISA should have robustness with standard filters and sensitivity comparable to classical ELISA; two immuno-reaction systems of no crossreactivity, a suitable pair of chromogenic substrates and a proper pair of enzyme labels are mandatory biomaterials. Currently, the first two are already available, but it is hard to access a suitable pair of enzyme labels.
Among putative labels, hydrolytic enzymes are considered for their high specificity and the ease to design their chromogenic [10] [11] [12] One of the phosphate and glycosides of 4-nitro-1-naphthol thus serves as substrate A and 4-nitro-1-naphthylphosphate (4NNPP) is better for the longest isoabsorbance wavelength closer to 405 nm; [10] [11] [12] [13] one of the esters/glycosides/sulfate of 4-nitrophenol/analogue serves as substrate B. [10] [11] [12] [13] On the other hand, a proper pair of enzyme labels should suffer from no inhibition, inactivation or activation by substances involved in SDESA; for reliable assay of enzyme activity, a suitable pair of enzyme labels should have optimum buffers at neutral or alkaline pH to facilitate continuous monitoring of reactions. 13 Moreover, for comparable sensitivity, a proper pair of enzyme labels should have sufficiently high activities in the same buffers. On chromogenic substrates derived from 4-nitro-1-naphthol as substrate A, alkaline phosphatase as label A has much higher activity than glycosidases. 13, 16 Hence, label B should have high activity in buffers optimum for alkaline phosphatase.
Based on optimum buffers, acetylcholinesterase from Electrophorus electricus (AChE) is a candidate for label B since it has high activity with acetylthiocholine (ATCh) and 5,5′-dithio-bis-(2-nitrobenzoic acid) (DTNB) as the chromogenic substrate system (Scheme S1, Supporting Information). 17 The reduction of DTNB by sulfhydryl gives 2-nitro-5-thiobenzoic acid (NTB), an analogue of 4-nitrophenol. However, for spectral properties of chromogenic products to match with standard filters of microplate readers, 4-nitrophenol is favorable over NTB. To the best of our knowledge, few other carboxyl esterases have optimum buffers compatible with alkaline phosphatase and sufficient activities on carboxyl esters of 4-nitrophenol; glycosidases exhibit optimum buffers incompatible with alkaline phosphatase besides their inherently low activities on glycosides of 4-nitrophenol. 10, 11, 13 Moreover, snail arylsulfatase is an ELISA label, but its optimum buffer is incompatible with alkaline phosphatase. 18 Fortunately, Pseudomonas aeruginosa arylsulfatase (PAAS) has optimum buffers compatible with alkaline phosphatase (Scheme S1). 19 Thus, AChE and PAAS are candidates of label B and should be compared.
Currently, to the best of our knowledge, there are two candidates of alkaline phosphatase to serve as label A. One is calf intestinal alkaline phosphatase (CIAP) whose highest activity on 4-nitrophenylphosphate may rank the first among reported enzyme labels. [10] [11] [12] [13] [14] [15] Importantly, the activity of CIAP on 4NNPP accounts for about one-third of that on 4-nitrophenylphosphate. 16 The other is an engineered alkaline phosphatase of Eschrichia coli (ECAP) commercialized recently (http://www.biotrand.com/web/cn/product_hot.php).
The highest activity of ECAP on 4-nitrophenylphosphate is about one-third of that of CIAP, but that on 4NNPP is unknown. However, CIAP is susceptible to DTNB for AChE assay while ECAP has good resistance to DTNB. Molecular engineering is plausible to improve activity of a label for SDESA. In the present study, therefore, AChE was compared against PAAS for SDESA with ECAP to select a candidate for label B for subsequent molecular engineering.
Experimental

Chemicals, materials and instruments
Potassium 4-nitrophenylsulfate (4NPS), ATCh, DTNB, isopropyl-β-D-thiogalactoside (IPTG), CIAP (EC 3.1.3.1) and AChE (EC 3.1.1.7) were purchased from Sigma-Aldrich. ECAP and Ni 2+ -NTA-agarose were purchased from Beijing Biotrand Biotechnology Co., Ltd. (Beijing, China; http://www.biotrand. com/web/cn/product_hot.php). Syntheses of coding DNA of PAAS, sequencing of DNA and construction of expression vector were performed by Beijing Taihe Gene Biotechnology Co., Ltd. (Beijing, China). 4NNPP was synthesized as reported in an early study. 10 Other chemicals were domestic analytical products.
To record absorbance spectra during enzyme reactions, a computer-controlled Shimadzu UV-2550 was used. To record reaction curve for either separate assay or SDESA, an MAPADA UV-1600 spectrophotometer controlled by dedicated software provided by the manufacturer was used as described in the early reports (http://www.mapada.com.cn/showcp.php?id=27).
10,11
Recombinant expression and purification of PAAS
Coding sequence of PAAS (EC 3.1.6.1) was synthesized (GI: 879288), 19 and inserted into a pET24a vector bearing a sixhistidine tag at the N-terminus via a short neutral flexible linker. 20 To calibrate activity unless otherwise stated, PAAS activity was measured in 0.50 M Tris-HCl buffer at pH 9.5 with 1.0 mM 4NPS.
After amplification of the vector in Escherichia coli
Monitoring of reaction curves
Two substrate systems were used in the same reaction mixtures for SDESA while just one substrate/system was used for separate assay.
For SDESA, wavelengths on MAPADA UV-1600 spectrophotometer were swiftly altered (within 1.0 s between 405 nm as λ2 and 450 nm as λ1); absorbance at indicated wavelength(s) of a reaction solution was measured manually at intervals of 10 s in a total of 90 s. 10, 11 Data were output into MS Excel 6.0 for further analyses. An indicated buffer was incubated at 25 C for more than 20 min before use so that enzyme reaction can occur at 25 C.
Final levels were 0.20 mM 4NNPP for alkaline phosphatase, 0.50 mM ATCh plus 0.50 mM DTNB for AChE, and 1.0 mM 4NPS for PAAS, in an indicated buffer. Stock solution of 4NNPP was prepared in dimethylsulfoxide at concentrations over 20 mM so that final levels of dimethylsulfoxide were below 1% in reaction mixtures to avoid potential interference of dimethylsulfoxide with enzyme actions. Stock solutions of ATCh and DTNB, and 4NPS, were separately prepared in water at levels over 20-fold of their final levels. To monitor spontaneous hydrolysis of 4NPS or 4NNPP, reaction was continuously recorded for 30 min, unless otherwise stated.
Derivation of activities of two enzymes by SDESA
Product A and B had the maximum difference absorbance peaks versus their substrates close to λ1 of 450 nm and λ2 of 405 nm, respectively. By swift alternation of two wavelengths, absorbance at λ1 and λ2 of a reaction mixture was recorded concomitantly at proper internals. To derive absorbance change rates of product A at λ1 and product B at λ2, and then initial rates free of interference of involved substances, a series of symbols were needed. 10, 11 Among such symbols, R12 was the ratio of the difference in the molar absorption coefficient of 4-nitro-1-naphthol versus 4NNPP at λ2 to that at λ1, and R21 was the ratio of the difference in the molar absorption coefficient of 4-nitrophenol/analogue versus the corresponding chromogenic substrate(s) at λ1 to that at λ2. As a result, R12 indexed the degree of the overlapped absorbance of product A at 405 nm while R21 reflected the degree of the overlapped absorbance of product B at 450 nm. Details for the derivation of initial rates of absorbance change for two enzymes and associated equations are provided as Note S1 in the Supporting Information.
Other methods for data processing
Unless otherwise stated, enzyme activity was presented as the change rate of absorbance. Results were represented as mean ± standard deviation (SD) to estimate coefficient of variation (CV). Limit of detection (LOD) is the sum of absorbance change rate of non-enzymatic reaction plus three times SD of absorbance change rates in the absence of any enzyme; limit of quantification (LOQ) of an enzyme is the sum of LOD plus five times the standard error of estimate for linear response (STEYX). Upper limit refers to the largest activity bearing a deviation from linear response below twice STEYX. Other methods for data processing followed those described previously.
10,11
Results
SDESA of ECAP and AChE
Spectral properties of chromogenic substrate/product of AChE were examined. Changes of absorbance spectra during actions of ECAP and AChE supported that 4NNPP and ATCh plus DTNB was potentially a proper pair of substrate systems for SDESA (Fig. 1) . The longest isoabsorbance wavelength of 4NNPP was about 405.8 nm at pH 8.0 to 10.0. Of NTB, the difference absorbance reached a peak at about 412 nm, and remained at a plateau to 405 nm. Spontaneous hydrolysis of 4NNPP in 0.60 M Tris-HCl buffer at pH 9.0 was very slow; the increase in absorbance at 450 nm in 10 min was about (0.0060 ± 0.0004) (n = 5). Unfortunately, there was rapid spontaneous hydrolysis of ATCh in 0.60 M Tris-HCl buffer at pH 9.0; the increase in absorbance at 405 nm for spontaneous hydrolysis of ATCh at 0.50 mM was over 0.030 per min; spontaneous hydrolysis rates of ATCh were proportional to Tris concentrations, and increased at higher pH values of buffers (Fig. S1a,  Supporting Information) . However, 4NNPP displayed negligible spontaneous hydrolysis under the same conditions (Figs. S1b and S2, Supporting Information).
To enhance SDESA of ECAP and AChE, buffer media and pH values were optimized. The assay of alkaline phosphatase usually utilizes alkaline Tris-HCl or DEA-HCl buffer. ECAP showed stronger activities in DEA-HCl buffer at the tested pH values, but AChE in DEA-HCl buffer at pH values from 8.0 to 9.0 showed much lower activities than in Tris-HCl buffers of the same pH values (Fig. S3, Supporting Information) . On the other hand, in Tris-HCl buffers over tested ranges of pH and concentrations of Tris, AChE displayed much higher activities than ECAP on 4NNPP (Fig. S4, Supporting Information) ; thus, buffers were optimized for the activity of ECAP as high as possible. ECAP activities were positively associated with concentrations of Tris smaller than 0.70 M (Fig. S4) . Moreover, ECAP activities showed just slight increases at pH over 9.0 (Fig. S4) . Therefore, 0.60 M Tris-HCl at pH 9.0 was selected for SDESA of AChE and ECAP.
ECAP was resistant to sodium phosphate up to 50 μM. The Michaelis-Menten constant (Km) of ECAP for 4NNPP was about 0.14 mM, which was much higher than that of CIAP for 4NNPP. 16 As a result, 4NNPP at high levels was needed for the assay of initial rate of ECAP with wide linear ranges. However, the strong absorbance of 4NNPP at 405 nm limited its final concentrations to about 0.20 mM so that there was a reasonable range to measure absorbance at 405 nm for NTB. In this case, the highest activity of ECAP was over 270 kU g -1 while that of AChE was over 670 kU g -1 (Fig. S4) . On the other hand, the highest activity of CIAP on 0.20 mM 4NNPP in 0.60 M Tris-HCl at pH 9.0 was over 680 kU g -1 . Unfortunately, the incubation of CIAP with 0.50 mM DTNB for just 2.0 min caused the loss of CIAP activity by (55 ± 5) % (n = 3), indicating that CIAP was susceptible to DTNB and unsuitable for SDESA with AChE. Fortunately, ECAP was resistant to 0.5 mM ATCh plus 0.50 mM DTNB after the incubation for 30 min. 4NNPP at 0.20 mM and sodium phosphate at 1.0 mM did not alter AChE action; 4-nitro-1-naphthol at levels below 0.05 mM had no effect on AChE action. Therefore, SDESA of ECAP and AChE had potential robustness.
For SDESA of ECAP and AChE in 0.60 M Tris-HCl at pH 9.0, R12 as the ratio of the difference of the molar absorption coefficient of 4-nitro-1-naphthol versus 4NNPP at 405 nm to that at 450 nm was (-0.018 ± 0.001) (n = 3), which indicated slight negative interference from 4NNPP with the absorbance at 405 nm for NTB and minor roles of the correction of the overlapped absorbance in estimating absorbance change rate at 405 nm. However, NTB had manifest absorbance at 450 nm (Fig. 1) ; R21 for NTB at 450 nm to that at 405 nm was as large as (0.58 ± 0.02) (n = 3) and was mandatory for data processing to alleviate interference of the overlapped absorbance of NTB with that of 4-nitro-1-naphthol (Fig. S5, Supporting  Information) . Interestingly, at λ2 of 406 nm, R12 was (-0.0014 ± 0.0001) (n = 3); the use of larger λ1 always gave smaller R21 since the wavelength for measuring absorbance of 4-nitro-1-naphthol as product A was farther away from the difference absorbance peak of product B (Table S1 , Supporting Information). These results support the use of larger λ1 to alleviate interference of NTB or analogue with the absorbance of 4-nitro-1-naphthol, but there was potential reduction of sensitivity for quantifying 4-nitro-1-naphthol; this contradiction resulted in the need of the chemometric method for the correction of overlapped absorbance of two pairs of chromogenic substrates/products. In this case, SDESA of ECAP and AChE had slopes, LODs, LOQs and upper limits as absorbance change rates comparable to those by separate assay with just one substrate, respectively, when activity ratios of ECAP to AChE were varied from 0.05 to 20.0 (Fig. 2, Table S2 (Supporting Information)).
SDESA of ECAP and PAAS
In neutral phosphate buffer, the maximum difference absorbance peak of 4-nitrophenol versus glycoside substrate was close to 400 nm; 11 in Tris-HCl or DEA-HCl buffer at pH over 8.0, the maximum difference absorbance peak of 4-nitrophenol versus 4NPS was close to 405 nm (Fig. 3) . The longest isoabsorbance wavelengths for 4NNPP at pH values over 8.0 were consistently about 406 nm while the maximum difference absorbance peak of 4-nitro-1-naphthol versus 4NNPP was close to 458 nm. Hence, spectral properties of 4NNPP and 4NPS better met the requirements of SDESA with conventional microplate readers. 10, 11 DEA-HCl buffers were unfavorable for AChE, but better than Tris-HCl buffers for ECAP, CIAP and PAAS. More importantly, in DEA-HCl buffer at pH 10.0, the increase in absorbance at 450 nm in 10 min due to spontaneous hydrolysis of 4NNPP was about (0.0030 ± 0.0005) (n = 5), which was about half of that in Tris-HCl buffer of the same pH. 4NPS displayed even smaller spontaneous hydrolysis rates than 4NNPP in DEA-HCl buffers over the same pH range (Fig. S1c, Supporting Information) . Such rates of spontaneous hydrolysis were nearly twomagnitudes lower than that of ATCh in 0.60 M Tris-HCl buffer at pH 9.0 (Figs. S1a, S1b and S1c, Supporting Information). Moreover, in DEA-HCl buffer at pH from 9.0 to 10.0, activities of ECAP and PAAS were higher than those in Tris-HCl buffers. Hence, DEA-HCl buffer was better suited for SDESA of ECAP and PAAS. In 1.0 M DEA-HCl buffer at pH from 9.8 to 10.8, ECAP reached its highest activity of 320 kU g -1 on 0.20 mM 4NNPP while PAAS reached its highest activity at pH 10.0 to 10.5. Considering the effects of pH on spontaneous hydrolysis, pH 10.0 was selected for SDESA of ECAP and PAAS. PAAS activities were positively associated with the concentrations of DEA, but the activities of ECAP reached a plateau at DEA concentrations from 0.8 to 1.0 M (Fig. S6, Supporting  Information) . As a result, 1.0 M DEA-HCl buffer at pH 10.0 was used. Moreover, in 1.0 M DEA-HCl buffer at pH 10.0, the highest activity of CIAP on 0.20 mM 4NNPP was over 1000 kU g -1 . PAAS had Km of about 15 μM for 4NPS and just 1.0 mM 4NPS was sufficient for the assay of PAAS. However, PAAS inherently had the highest activity of just about 40 kU g -1 under optimum conditions. Furthermore, both ECAP and CIAP were resistant to sodium sulfate up to 0.50 mM and 4NPS up to 5.0 mM, while PAAS was also resistant to sodium phosphate up to 1.0 mM; 4-nitro-1-naphthol and 4-nitrophenol at levels below 0.05 mM had no effect on the actions of ECAP, CIAP and PAAS. Therefore, SDESA of PAAS plus ECAP or CIAP had potential robustness.
For SDESA of ECAP and PAAS in 1.0 M DEA-HCl buffer at pH 10.0, R12 for 4-nitro-1-naphthol versus 4NNPP at 405 nm to that at 450 nm was (-0.017 ± 0.001) (n = 3), consistent with that in 0.60 M Tris-HCl buffer at pH 9.0. However, 4-nitrophenol still had clear absorbance at 450 nm; R21 for 4-nitrophenol versus 4NPS at 450 nm to that at 405 nm was (0.192 ± 0.005) (n = 3), about one-third of that of NTB at pH 9.0 (Fig. S7 , Supporting Information). With λ2 of 406 nm, R12 was reduced by about six-fold; when λ1 was preset at 460 nm, R21 was reduced by more than 50% (Table S3 , Supporting Information). Thus, for SDESA of ECAP and PAAS, the correction of overlapped absorbance of 4-nitrophenol and 4-nitro-1-naphthol according to the proposed chemometric method was still mandatory. In this case, SDESA of ECAP and PAAS had slopes, LODs, LOQs and upper limits indexed by absorbance change rates comparable to those by separate assay with one substrate, when activity ratios of ECAP to AChE were varied from 0.05 to 20.0 (Fig. 4 , Table S4 (Supporting Information)). Therefore, SDESA of ECAP and PAAS was effective.
Discussion
For the practicability of SDESA-ELISA, conventional microplate readers equipped with standard filters centering on 405 and 450 nm should be applicable. For robustness of SDESA-ELISA, two chromogenic substrates/products should have special spectral properties to alleviate the interference of overlapped absorbance of involved substances, and both labels should tolerate negligible interferene from substances involved in SDESA. 10, 11 For sensitivity comparable to classcial ELISA, two labels in an optimized buffer should have sufficient activities. For the ease to prepare instant liquid reagent kits, substrates and labels should have sufficient stability. A suitable pair of chromogenic substrates and a proper pair of labels are thus sought for SDESA-ELISA.
After screening, 4-nitro-1-naphthylphosphate was selected as substarte A while one of the sulfate/esters/glycosides of 4-nitrophenol/analogue was needed to serve as substrate B. The maximum absorbance wavelength of 4-nitro-1-naphthol was close to 450 nm while the longest isoabsorbance wavelength of 4NNPP was close to 405 nm, supporting negligible increase in absorbance at 405 nm due to the hydrolysis of 4NNPP as substrate A. During SDESA, thus, the change of absorbance at 405 nm originated predominantly from the variations of concentrations of product B while that at 450 nm mainly orginated from the variations of concentrations of product A. Clearly, there was interference from the overlapped absorbance of substances involved in SDESA. The processing of data by the chemometric method eliminated such interference. After correction of spontaneous hydrolysis, initial rate of absorbance change at 450 nm thus reflected activity of label A while that at 405 nm indexed activity of label B. SDESA-ELISA was proved effective with alkaline phosphatase as a proper candidate for label A. 10, 11 However, for satisfactory sensitivity, label B of sufficient activtiy in buffers optimum for alkaline phosphatase was mandatory but currently inaccessible.
Horseradish peroxidase as the classical label has an activity over 200 kU g -1 while its chromogenic product has a molar absorption coefficient of about 72.0 (mM) -1 cm -1 . 21 For classical ELISA, peroxidase reaction usually lasts for 20 min and is terminated by acidification before absorbance assay. Molar absorption coefficients of 4-nitro-1-naphthol at 450 nm and 4-nitrophenol at 405 nm are about 27.0 (mM) - A should have activity over 400 kU g -1 , if reaction period of 20 min is utilized; when reaction periods are prolonged, lower activities of two hydrolytic enzymes are still able to provide comparable sensitivity to SDESA-ELISA. For robustness of SDESA, label B should be resistant to substrate/products of alkaline phosphatase, and introduce no substrates/products to alter alkaline phosphatase action. CIAP has sufficient activity on 4NNPP under the optimum conditions. Enzyme activity is susceptible to reaction pH. By molecular engineering, activities of enzymes can be effectively improved. Notably, the engineering of one label for sufficient activity is more favorable than the engineering of two labels and thus label B is required to have optimum buffers compatible with CIAP. AChE and PAAS are thus candidates of label B for comparison of SDESA with alkaline phosphatase.
4NNPP as substrate A had strong absorbance even at the longest isoabsorbance wavelength of 405 nm. 10 For a reasonable range to measure absorbance at 405 nm of product B with conventional microplate readers, final levels of substrate A were limited to about 0.20 mM. NTB absorbance overlapped with the absorbance of 4-nitro-1-naphthol. However, the use of the proposed chemometric method to process data effectively eliminated the interference of overlapped absorbance of substances involved in SDESA (Table S2 ). AChE and ECAP are commercialized labels. ECAP had resistance to chromogenic substrate system of AChE and excellent stability. In 0.60 M Tris-HCl buffer at pH 9.0 for SEDSA, ECAP and AChE already had activities high enough to serve as labels for comparable sensitivity of SDESA-ELISA if reaction periods were optimized. At the present time, thus, the combination of ECAP on 4NNPP with AChE on ATCh plus DTNB may be practical for SDESA-ELISA when shelf lives of the reagent kits can be improved. ATCh in the optimized Tris-HCl buffer tolerates fast spontaneous hydrolysis, but its solid powder still has sufficient stability. To prolong shelf lives of reagent kits with AchE and ECAP, powders of mixtures of two substrate systems can be prepared for the dissolution in the optimized buffer just before use. Clearly, the instant use of such reagent kits is prevented in clinical laboratories.
Spectral properties of chromogenic substrates/products made ECAP or CIAP plus PAAS prefereable for SDESA and results supported effectiveness of their SDESA. Importantly, 4NNPP and 4NPS displayed negligible spontaneous hydrolysis, supporting the advantage to use alkaline phosphatase and PAAS as a pair of enzyme labels for the preparation of instant liquid reagent kits to practice SDESA-ELISA. In 1.0 M DEA-HCl buffer at pH 10.0, ECAP already had reasonable activity for comparable sensitivity of SDESA-ELISA while CIAP had much higher activity on 0.20 mM 4NNPP. Moreover, CIAP has stronger affinity for 4NNPP, 16 and thus the use of 0.20 mM 4NNPP can provide wider linear range for the assay of activity of CIAP. However, PAAS inherently had low activity on 4NPS besides catalytic promiscuity to hydrolyze phosphates. [22] [23] [24] Fortunately, the activity of PAAS on 0.20 mM 4NNPP was less than 0.07% of that on 1.0 mM 4NPS; molecular engineering was feasible to provide a mutant of PAAS of sufficiently high activity on 4NPS while negligible activity on 0.20 mM 4NNPP in buffers optimum for alkaline phosphatase. In general, enzyme molecular engineering can utilize rational design of mutants or directed evolution. Rational design of mutants needs a three-dimensional structure and catalytic mechanism, which are partially accessible with PAAS to facilitate rational design of high-activity mutants. In practice, however, rational design of mutants is still technically challenging and relies on the use of computation resources. [22] [23] [24] [25] On the other hand, based on the known three-dimensional structure and catalytic mechanism of PAAS, iterative saturation mutagenesis of rationally-selected sites for directed evolution is efficient and much easier to enhance catalytic activities of mutants. [26] [27] [28] Hence, an engineered PAAS bearing sufficient activity on 4NPS appears promising for the practice of SDESA-ELISA in the future.
Conclusions
The pair of ECAP and AChE had sufficiently high activities in an optimized buffer, but the differences in spectral properties and stability of chromogenic substrates supported that the pair of alkaline phosphatase and PAAS was more preferable for SDESA. To serve as label B plus alkaline phosphatase as label A for SDESA-ELISA, however, PAAS should be engineered for the activity over 600 kU g -1 on 4NPS while negligible activity on 0.20 mM 4NNPP.
